News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Retrophin, LLC and St. Jude Children's Research Hospital to Collaborate on Rare Disease Research Program



7/16/2012 9:54:12 AM

NEW YORK--(BUSINESS WIRE)--Retrophin, LLC, a privately-held New York-based, biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases, today announced that it has entered a sponsored research agreement with St. Jude Children’s Research Hospital. Retrophin will supply funding and a library of replacement therapy compounds for St. Jude to test for potential use in the treatment of PKAN disease.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES